Review: Transfusing incompatible RBCs - Clinical aspects

Immunohematology

Volumn 20, Issue 3, 2004, Pages 161-166

  Meny, Geralyn ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPYRETIC AGENT; BILIRUBIN; CHROMIUM 51; ERYTHROCYTE ANTIBODY; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; UROBILINOGEN;

ADULT; AGE; AGED; ANEMIA; BIOASSAY; BLOOD GROUP INCOMPATIBILITY; BLOOD SMEAR; BLOOD TRANSFUSION REACTION; CARDIOVASCULAR FUNCTION; CASE REPORT; CELL ASSAY; CHEMOLUMINESCENCE; CLINICAL TRIAL; CROSSMATCHING; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOGLOBINEMIA; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; LABORATORY TEST; LEUKAPHERESIS; MONOCYTE MONOLAYER ASSAY; MORTALITY; PATIENT MONITORING; PREMEDICATION; PRIORITY JOURNAL; RETICULOCYTE COUNT; REVIEW; SICKLE CELL ANEMIA; TREATMENT INDICATION;

ADULT; AGED; AUTOANTIBODIES; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; MALE; RISK ASSESSMENT;

EID: 4444265628     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Oberman HA. The history of transfusion medicine. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996:11-32.
2. Hoffman R, Benz EJ Jr, Shattil SJ, et al., eds. Hematology basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:367-75.
3. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000;92:1646-52.
4. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348: 1055-60.
5. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
6. Popovsky MA, Audet AM, Andrzejewski C. Transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunohematology 1996;12:87-9.
7. Popovsky MA. Circulatory overload. In: Popovsky MA, ed. Transfusion reactions. 2nd ed. Bethesda, MD: American Association of Blood Banks, 2001: 255-60.
8. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego: Academic Press, 2003.
9. International Committee for Standardization in Hematology. Recommended method for radio-isotope red-cell survival studies. Br J Haematol 1980;45:659-66.
10. Mollison PL. Survival in vivo as a test for red cell compatibility. Haematologia 1972;6:139-45.
11. Davenport RD. Hemolytic transfusion reactions. In: Popovsky MA, ed. Transfusion reactions. 2nd ed. Bethesda, MD: American Association of Blood Banks, 2001:1-44.
12. Mechanisms of immune hemolysis. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:133-65.
13. Langley GR, Owen JA, Padanyi R. The effect of blood transfusion on serum haptoglobin. Br J Haematol 1962;8:392-9.
14. The diagnosis of hemolytic anemias. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:33-60.
15. Trainor LD, Solomon HM. Detecting myoglobinuria: a low-tech analysis. Lab Med 1997;28:569-71.
16. Jacobs DS, Garg U, Oxley DK. Chemistry. In: Jacobs DS, Oxley DK, DeMott WR, eds. Laboratory test handbook. 5th ed. Hudson, OH: Lexi-Comp, 75-302.
17. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
18. Cullis JO, Win N, Dudley JM, Kaye T. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995;69:355-7.
19. King KE, Shirley RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997;37:376-81.
20. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
21. Cullis JO, Win N, Dudley JM, Kaye T. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995;69:355-7.